|
|
 |
 |
 |
 |
 |
 |
| Subject Categories:
Membranes & Transport
| Differentiation & Death
|
 |
The EMBO Journal
(2006) 25, 2287–2296, doi:10.1038/sj.emboj.7601126 Published online 27 April 2006
|
 |
| Bcl-2 changes conformation to inhibit Bax oligomerization |
 |
 |
|
Paulina J Dlugosz1, Lieven P Billen1, Matthew G Annis1, Weijia Zhu1, Zhi Zhang3, Jialing Lin3, Brian Leber1, 2 and David W Andrews1
|
 |
1 Department of Biochemistry and Biomedical Sciences, McMaster University Health Sciences Centre, CDN-Hamilton, Ontario, Canada
2 Department of Medicine, McMaster University Health Sciences Centre, CDN-Hamilton, Ontario, Canada
3 Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
To whom correspondence should be addressed
David W Andrews, Department of Biochemistry and Biomedical Sciences, McMaster University Health Sciences Centre, 4H41B-1200 Main Street West, CDN-Hamilton, Ontario, Canada L8N 3Z5. Tel.: +1 905 525 9140 ext 22075; Fax: +1 905 522 9033; E-mail: andrewsd@mcmaster.ca
Received 3 November 2005; Accepted 11 April 2006; Published online 27 April 2006.
|
 |
 |
 |
| Abstract |
 |
Bcl-2 inhibits apoptosis by regulating the release of cytochrome c and other proteins from mitochondria. Oligomerization of Bax promotes cell death by permeabilizing the outer mitochondrial membrane. In transfected cells and isolated mitochondria, Bcl-2, but not the inactive point mutants Bcl-2-G145A and Bcl-2-V159D, undergoes a conformation change in the mitochondrial membrane in response to apoptotic agonists such as tBid and Bax. A mutant Bcl-2 with two cysteines introduced at positions predicted to result in a disulfide bond that would inhibit the mobility of 5– 6 helices (Bcl-2-S105C/E152C) was only active in a reducing environment. Thus, Bcl-2 must change the conformation to inhibit tBid-induced oligomerization of integral membrane Bax monomers and small oligomers. The conformationally changed Bcl-2 sequesters the integral membrane form of Bax. If Bax is in excess, apoptosis resumes as Bcl-2 is consumed by the conformational change and in complexes with Bax. Thus, Bcl-2 functions as an inhibitor of mitochondrial permeabilization by changing conformation in the mitochondrial membrane to bind membrane-inserted Bax monomers and prevent productive oligomerization of Bax. |
 |
| Keywords: apoptosis, Bax, Bcl-2, membrane topology, tBid |
 |
 |
 |
Top of page MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated |  |
 |
|
 |
|